We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Progenics Announces Initiation of RELISTOR Clinical Trials in Japan by Ono Pharmaceutical

News   Jun 09, 2009

 
Progenics Announces Initiation of RELISTOR Clinical Trials in Japan by Ono Pharmaceutical
 
 
 

RELATED ARTICLES

Targeting Enzyme “Bottleneck” Reveals Novel Anticancer Drug Strategy

News

The enzyme ribonucleotide reductase is a bottleneck for cancer cell growth. Scientists have now identified a way of targeting ribonucleotide reductase that may avoid the toxicity of previous approaches, informing focused drug discovery efforts.

READ MORE

Compound Created to Block Therapeutic Target in Blood Cancer

News

Researchers have discovered a hyperactive cell signal that contributes to tumor growth in an aggressive blood cancer. The team has also developed an experimental therapeutic "UNC3810A" to block the signal and slow tumor growth.

READ MORE

HIV Vaccine Is a Step Closer to Clinical Trials

News

A promising vaccine that clears an HIV-like virus from monkeys is a step closer to human testing after a new, weakened version of the vaccine has been shown to provide similar protection as its original version.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE